Hsbc Holdings PLC Purchases Shares of 46,892 Sotera Health Company $SHC

Hsbc Holdings PLC acquired a new stake in Sotera Health Company (NASDAQ:SHC) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 46,892 shares of the company’s stock, valued at approximately $833,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. CenterBook Partners LP lifted its stake in Sotera Health by 94.1% during the fourth quarter. CenterBook Partners LP now owns 151,529 shares of the company’s stock worth $2,673,000 after purchasing an additional 73,473 shares during the period. Capricorn Fund Managers Ltd acquired a new stake in Sotera Health during the fourth quarter valued at approximately $7,936,000. Nordea Investment Management AB bought a new stake in shares of Sotera Health in the 4th quarter valued at approximately $1,908,000. Retirement Systems of Alabama grew its stake in shares of Sotera Health by 16.9% in the 4th quarter. Retirement Systems of Alabama now owns 248,899 shares of the company’s stock valued at $4,391,000 after purchasing an additional 35,974 shares during the period. Finally, Exchange Traded Concepts LLC acquired a new position in shares of Sotera Health in the 4th quarter worth approximately $7,739,000. 91.03% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

SHC has been the subject of several analyst reports. Weiss Ratings upgraded Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. UBS Group set a $19.00 price objective on Sotera Health in a research note on Wednesday, June 24th. Barclays increased their price objective on Sotera Health from $18.00 to $19.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 24th. Piper Sandler reissued an “overweight” rating and set a $22.00 price objective (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Finally, Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $20.25.

Sotera Health Stock Performance

NASDAQ SHC opened at $17.78 on Wednesday. Sotera Health Company has a 1-year low of $10.94 and a 1-year high of $19.85. The company has a 50 day moving average of $16.32 and a 200-day moving average of $16.39. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56. The firm has a market cap of $5.07 billion, a price-to-earnings ratio of 43.37 and a beta of 1.76.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. During the same period in the prior year, the company earned $0.14 EPS. Sotera Health’s revenue for the quarter was up 10.0% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, equities analysts forecast that Sotera Health Company will post 0.87 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 15.36% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.